Magnite to Announce Second Quarter 2024 Financial Results on August 7, 2024
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the world’s largest independent sell-side advertising company, will announce […]
Adeia Renews Long-Term IP License Agreement with Liberty Global
SAN JOSE, Calif., July 08, 2024 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA) (“Adeia” or “Company”), the company whose patented […]
NextNav Granted Department of Transportation Award to Test PNT Services as a Complement and Backup to GPS
RESTON, Va., July 08, 2024 (GLOBE NEWSWIRE) — NextNav (Nasdaq: NN) (“NextNav” or the “Company”), a leader in next generation […]
NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively
LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of […]
Rocky Mountain Chocolate Factory Schedules Fiscal First Quarter 2025 Conference Call for July 15, 2024 at 5:00 P.M. ET
DURANGO, Colo., July 08, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), […]
Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024
REDWOOD CITY, Calif., July 08, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
Nasdaq Reports June 2024 Volumes and 2Q24 Statistics
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for June 2024, as well […]
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest […]
AvidXchange Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
CHARLOTTE, N.C., July 08, 2024 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) […]
Kymera Announces Expansion of KT-474 (SAR444656) HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new […]
